Distributors

AUSUPREME

AUSUPREME 将于 6 月 29 日盘中 (北京时间) 发布 FY2026 年度财报

AUSUPREME released FY2026 Q1 earnings on November 26, 2025 (BJT) with actual revenue of HKD 72.49 M and EPS of HKD 0.0117

AUSUPREME released FY2026 Semi-Annual Earnings on November 26 During-Market BJT, actual revenue HKD 144.97 M, actual EPS HKD 0.0234

AUSUPREME released FY2026 Q2 earnings on November 26 During-Market (BJT), actual revenue HKD 72.49 M, actual EPS HKD 0.0117

AUSUPREME to Release FY2026 Semi-Annual Earnings on November 26, 2025 (BJT)

AUSUPREME released FY2025 Annual Earnings on June 26, 2025 (BJT) with actual revenue of HKD 269.57 M and EPS of HKD 0.0366

AUSUPREME released FY2025 9 Months Earnings on June 26 (BJT), actual revenue HKD 198.05 M, actual EPS HKD 0.027

AUSUPREME released FY2025 Q4 earnings on June 26 Post-Market (BJT), actual revenue HKD 71.51 M, actual EPS HKD 0.0096

AUSUPREME released FY2025 Q3 earnings on June 26 (BJT), actual revenue HKD 71.51 M, actual EPS HKD 0.0096

Austop announces HKD 0.02 per share final dividend for FY2025

AUSupreme International Holdings Sees Revenue Growth but Net Profit Decline in FY2025

AUSUPREME to Release FY2025 Annual Earnings on June 26, 2025 (BJT)

Auzon International Holdings to Hold Board Meeting to Approve Financial Results and Discuss Dividends

Cai Zhihui Increases Stake in Aozhizun to 56.98%

Beatitudes International Ltd Increases Holdings in 澳至尊 (02031) by 280,000 Shares

AUSUPREME released FY2025 Q1 earnings on November 28, 2024 (BJT), with actual revenue of 63.27M HKD and EPS of 0.0087

AUSUPREME released FY2025 Semi-Annual Earnings on November 28 (BJT), with actual revenue of 126.54 M HKD and EPS of 0.0173 HKD

AUSUPREME released FY2025 Q2 earnings on November 28 (BJT), with actual revenue of 63.27 M HKD and EPS of 0.0086 HKD

AUSUPREME to Release FY2025 Semi-Annual Earnings on November 28, 2024 (BJT)

Aozhizun announces full-year performance for 2024

SINOFORTUNE FIN

PAN ASIA DATA H

HUASHENG INTL

IMAGI INT'L

SUPERLAND GROUP

QIANHAI HEALTH

STELUX HOLDINGS

JOLIMARK

CASSAVA RES

I-CABLE COMM

Earning Release Date

财报预告

FY2026 Annual Earning Release 2026.06.29

02031

Ausupreme International Holdings Ltd. reported strong interim results for 2025, with revenue of HK$144,972,000 and profit of HK$17,901,000, marking significant growth from 2024. The company's success in the health and wellness sector is due to effective cost management and increased sales, indicating positive prospects for stakeholders.

Tip Ranks

Ausupreme International Reports Strong Interim Results for 2025

AUSUPREME announced its interim results for the period ending September this year, with revenue of HKD 145 million, an increase of 14.6% year-on-year. During the period, profit was HKD 17.901 million, an increase of 35.2% year-on-year; earnings per share were 2.35 cents. No dividend was declared

AASTOCKS

"Performance" AUSUPREME's half-year profit rises 35.2% to HKD 17.9 million

The healthcare real-time location systems (RTLS) market is projected to reach US$10.66 billion by 2031, growing at a CAGR of 18.6%. A report by The Insight Partners highlights the increasing demand for patient tracking, asset management, and workflow optimization in hospitals, driven by the rise in chronic diseases. The growth is attributed to the benefits of precise tracking, improved workflows, and enhanced safety measures, indicating a significant trend towards adopting RTLS in healthcare facilities.

Unusual Whales

RTLS market for healthcare to reach US$10.66 billion by 2031, growing at CAGR of 18.6% due to rising chronic diseases.

The global market size of Consumer Packaged Goods (CPG) was estimated to be valued at USD 2,115,660 million in 2024. It is projected to increase to around USD 2,594,420 million by 2031.

Global CPG market worth $2.11 trillion in 2024, projected to reach $2.59 trillion by 2031 driven by health, sustainability, and e-commerce growth.

The global preservative-free eye drops market is projected to grow from US$1.21 billion in 2024 to US$1.67 billion by 2031, with a CAGR of 4.3%. This growth is driven by the rising prevalence of ocular diseases, an aging population, and increasing demand for chemical-free products. North America currently leads the market, while Asia Pacific is expected to experience the highest growth rate. The market is segmented by type, application, and distribution channel, with single-dose products and dry eye disease treatments holding significant shares.

prnewswire

National Vision

11:15 ET
			
			
				Preservative-Free Eye Drops Market Size to reach US$1.67 billion in 2031 | CAGR of 4.3% | Exclusive Report by The Insight Partners

AUSUPREME(02031.HK)

Ausupreme International Reports Strong Interim Results for 2025

"Performance" AUSUPREME's half-year profit rises 35.2% to HKD 17.9 million

RTLS market for healthcare to reach US$10.66 billion by 2031, growing at CAGR of 18.6% due to rising chronic diseases.

Global CPG market worth $2.11 trillion in 2024, projected to reach $2.59 trillion by 2031 driven by health, sustainability, and e-commerce growth.

11:15 ET Preservative-Free Eye Drops Market Size to reach US$1.67 billion in 2031 | CAGR of 4.3% | Exclusive Report by The Insight Partners

Trending